HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infliximab administration effective in the treatment of refractory Kawasaki disease.

AuthorsSalvatore Accomando, Andrea Liotta, Maria Cristina Maggio, Francesca Cardella, Giovanni Corsello
JournalPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (Pediatr Allergy Immunol) Vol. 21 Issue 7 Pg. 1091-2 (Nov 2010) ISSN: 1399-3038 [Electronic] England
PMID20977502 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Immunoglobulins, Intravenous
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Antibodies, Monoclonal (administration & dosage, adverse effects)
  • Conjunctivitis
  • Disease-Free Survival
  • Drug Resistance
  • Exanthema
  • Fever
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Immunotherapy
  • Infant
  • Infliximab
  • Lymphatic Diseases
  • Male
  • Mucocutaneous Lymph Node Syndrome (diagnosis, drug therapy, physiopathology)
  • Remission Induction
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: